Pharmaceuticals
Medical devices
The Draft Government Resolution “On Amendments to the Government Resolution #719 dd. July 17, 2015 “On Criteria for Classifying Products as Industrial Products Having no Analogues Produced in the Russian Federation”, placed by the Ministry for Industry and Trade, has passed public debates.
The proposed amendments introduce a number of criteria for each type of medical devices and pharmaceuticals to qualify them for products originating from Russia.
In particular, pharmaceuticals registered in Russia (including sera and vaccines) shall be deemed as Russia-manufactured products under the following conditions:
The Resolution is expected to come into force on October 1, 2015.
The Order of the Ministry of Healthcare #408n dd. July 2, 2015 approves the Administrative Regulation on Rendering the State Service of Issuance of an Approval for Importing into Russia Pharmaceuticals for the Purposes of Humanitary Aid or Emergency Aid.
The Regulation establishes timeline and sequence of administrative procedures performed at the applicant’s request, as well as the procedure of coordination between the Ministry’s departments and the applicants and other public authorities in course of the state service rendering.
The said state services are free of charge.
The state service shall be rendered within 10 business days maximum from the date of receiving the applicant’s documents by the Ministry of Healthcare.
The EuroAsian Economic Commission’s working group responsible for formation of general approaches to regulation of pharmaceuticals circulation in the EuroAsian Economic Community (EAEC) has developed the Draft Rules for registration and expert examination of pharmaceuticals for medical use.
The document is essential to create the EAEC common market of pharmaceuticals, which is supposed to start functioning from January 1, 2016. Starting from this date, all the safe, effective and high-quality pharmaceuticals should freely circulate within the Community.
The Rules contain detailed requirements to:
The draft Rules are posted on the websites of the EAEC and the Commission for the public debates.
The Order of the Ministry of Healthcare Order #419n dd. July 7, 2015 “On Adopting the Administrative Regulation on Rendering the State Service on Licensing Pharmaceutical Activity (except for Activities Carried out by Wholesalers of Pharmaceutical for Medical Use and Pharmacies Governed By Federal Executive Bodies and State Academies of Sciences) by Regional Executive Bodies” is registered with the Ministry of Justice of Russia on August 11, 2015 with number 38460 assigned.
According to the Regulation, regional executive bodies shall perform licensing for the following types of pharmaceutical activities:
The Regulation envisages, in particular:
National Assembly of Karachaevo-Cherkessia Republic initiated tightening of regulatory sanctions for licensing rules breach. The Draft Federal Law “On Amendments to the Code of Administrative Offences of the Russian Federation and Article 14 of the Federal Law “On Licensing of Certain Types of Activities” proposes to introduce a new type of liability into the Russian Code of Administrative Offences – removal of a pharmaceuticals license in cases of:
Upon the approval by the Parliament, the law will come into force on January 1, 2016.
On August 3, the Ministry for Industry and Trade placed for public debates the Draft Government Resolution “On Amendments to the Government Resolution #102 dd. February 5, 2015”.
The Draft Resolution envisages the following:
The previous Pharma Bulletin issues are accessible our site.
Prepared for you by KPMG in Russia and the CIS, Healthcare & Pharmaceuticals Sector.
© 2021 KPMG refers JSC “KPMG”, “KPMG Tax and Advisory” LLC, companies incorporated under the Laws of the Russian Federation, and KPMG Limited, a company incorporated under The Companies (Guernsey) Law, as amended in 2008, member firms of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organization please visit https://home.kpmg/governance.